Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

4% patients with COVID-19 shed fecal viral RNA 10 months after diagnosis

4% patients with COVID-19 shed fecal viral RNA 10 months after diagnosis

24 Apr 2022
Impact of COVID-19 vaccination on anti-nucleocapsid antibody levels

Impact of COVID-19 vaccination on anti-nucleocapsid antibody levels

24 Apr 2022
Study demonstrates increased incidence of SARS-CoV-2 Omicron breakthrough infection in cancer patients

Study demonstrates increased incidence of SARS-CoV-2 Omicron breakthrough infection in cancer patients

22 Apr 2022
How does SARS-CoV-2 infection affect the diversity of the gut microbiome?

How does SARS-CoV-2 infection affect the diversity of the gut microbiome?

22 Apr 2022
Efficacy of vaccination against SARS-CoV-2 Omicron BA.1 and BA.2 sublineages in Sweden

Efficacy of vaccination against SARS-CoV-2 Omicron BA.1 and BA.2 sublineages in Sweden

22 Apr 2022
Continual genomic surveillance in Africa provides insights into evolving SARS-CoV-2 pandemic

Continual genomic surveillance in Africa provides insights into evolving SARS-CoV-2 pandemic

22 Apr 2022
The diversity of transcriptional targets between four different coronavirus nsp1 proteins

The diversity of transcriptional targets between four different coronavirus nsp1 proteins

22 Apr 2022
Interleukin-6 levels predict early withdrawal of COVID-19 patients from mechanical ventilation

Interleukin-6 levels predict early withdrawal of COVID-19 patients from mechanical ventilation

22 Apr 2022
Study suggests SARS-CoV-2 is undergoing evolutionary changes at the functional RNA level in addition to the amino acid level

Study suggests SARS-CoV-2 is undergoing evolutionary changes at the functional RNA level in addition to the amino acid level

22 Apr 2022
Antibody escape in SARS-CoV-2 Omicron spike protein

Antibody escape in SARS-CoV-2 Omicron spike protein

22 Apr 2022
Study demonstrates that a low-dose, bivalent, unmodified mRNA vaccine against SARS-CoV-2 is highly efficacious

Study demonstrates that a low-dose, bivalent, unmodified mRNA vaccine against SARS-CoV-2 is highly efficacious

22 Apr 2022
Booster dose of BNT162b2 mRNA vaccine induces a high cross-neutralizing response against SARS-CoV-2 variants

Booster dose of BNT162b2 mRNA vaccine induces a high cross-neutralizing response against SARS-CoV-2 variants

22 Apr 2022
Rhinovirus the main virus co-circulating with SARS-CoV-2 in children

Rhinovirus the main virus co-circulating with SARS-CoV-2 in children

21 Apr 2022
COVID-19 mRNA vaccine protects against ICU admission for 1 year

COVID-19 mRNA vaccine protects against ICU admission for 1 year

21 Apr 2022
Antibodies that neutralize most sarbecoviruses, including SARS-CoV-2 variants

Antibodies that neutralize most sarbecoviruses, including SARS-CoV-2 variants

21 Apr 2022
SARS-CoV-2 spike protein disrupts lipid metabolism resulting in liver, heart & kidney damage

SARS-CoV-2 spike protein disrupts lipid metabolism resulting in liver, heart & kidney damage

21 Apr 2022
COVID-19 diagnosis in pregnancy and the postnatal period: Study

COVID-19 diagnosis in pregnancy and the postnatal period: Study

21 Apr 2022
CRISPR-based detection of SARS-CoV-2 RNA directly from patient swabs

CRISPR-based detection of SARS-CoV-2 RNA directly from patient swabs

21 Apr 2022
Physical and mental characteristics post-COVID-19 infection

Physical and mental characteristics post-COVID-19 infection

21 Apr 2022
Antibody-based treatment, endogenous immune responses, and within-host SARS-CoV-2 evolution in immunocompromised patients

Antibody-based treatment, endogenous immune responses, and within-host SARS-CoV-2 evolution in immunocompromised patients

21 Apr 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback